We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+20.4%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.42B
AUM Growth
+$226M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 43.93%
2 Consumer Staples 35.39%
3 Industrials 12.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.21B
$562M 39.52%
8,783,082
MNST icon
2
Monster Beverage
MNST
$94.3B
$503M 35.39%
9,312,976
AXON
3
Axon Enterprise
AXON
$42.5B
$171M 12.02%
760,062
IWM icon
4
iShares Russell 2000 ETF
IWM
$79.8B
$123M 8.66%
690,000
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$52.4M 3.69%
34,935,485
IMDX
6
Insight Molecular Diagnostics
IMDX
$150M
$8.28M 0.58%
1,167,685
SER icon
7
Serina Therapeutics
SER
$30M
$1.99M 0.14%
85,219

Similar funds

Broadwood Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Broadwood Capital held 7 positions worth $1.42B, up 19% from $1.2B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 40% a quarter earlier, followed by Consumer Staples and Industrials.

  • Broadwood Capital's ten largest holdings make up 100% of its $1.42B portfolio in Q1 2023.
  • Broadwood Capital opened 0 new positions and closed 0 in Q1 2023.
  • Broadwood Capital's portfolio value rose 19% quarter-over-quarter to $1.42B.

Based on Broadwood Capital's 13F filing for Q1 2023, filed 15 May 2023.